Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jul;54(5):568-74.
doi: 10.1016/j.comppsych.2012.12.001. Epub 2013 Jan 22.

The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms

Katiah Llerena  1 , Stephanie G Park, Julie M McCarthy, Shannon M Couture, Melanie E Bennett, Jack J Blanchard
Affiliations

The Motivation and Pleasure Scale-Self-Report (MAP-SR): reliability and validity of a self-report measure of negative symptoms

Katiah Llerena et al. Compr Psychiatry. 2013 Jul.

Abstract

The Clinical Assessment Interview for Negative Symptoms (CAINS) is an empirically developed interview measure of negative symptoms. Building on prior work, this study examined the reliability and validity of a self-report measure based on the CAINS-the Motivation and Pleasure Scale-Self-Report (MAP-SR)-that assesses the motivation and pleasure domain of negative symptoms. Thirty-seven participants with schizophrenia or schizoaffective disorder completed the 18-item MAP-SR, the CAINS, and other measures of functional outcome. Item analyses revealed three items that performed poorly. The revised 15-item MAP-SR demonstrated good internal consistency and convergent validity with the clinician-rated Motivation and Pleasure scale of the CAINS, as well as good discriminant validity, with little association with psychotic symptoms or depression/anxiety. MAP-SR scores were related to social anhedonia, social closeness, and clinician-rated social functioning. The MAP-SR is a promising self-report measure of severity of negative symptoms.

PubMed Disclaimer

References

    1. Blanchard JJ, Horan WP, Collins LM. Examining the latent structure of negative symptoms: Is there a distinct subtype of negative symptom schizophrenia? Schizophrenia Research. 2005 Sep;77(2–3):151–165. PubMed PMID: WOS:000231749100004. - PubMed
    1. Blanchard JJ, Kring AM, Horan WP, Gur R. Toward the Next Generation of Negative Symptom Assessments: The Collaboration to Advance Negative Symptom Assessment in Schizophrenia. Schizophrenia Bulletin. 2011 Mar;37(2):291–299. PubMed PMID: WOS:000287745300012. - PMC - PubMed
    1. Forbes C, Blanchard JJ, Bennett M, Horan WP, Kring A, Gur R. Initial development and preliminary validation of a new negative symptom measure The Clinical Assessment Interview for Negative Symptoms (CAINS) Schizophrenia Research. 2010 Dec;124(1–3):36–42. PubMed PMID: WOS:000285323700005. - PMC - PubMed
    1. Horan WP, Kring AM, Blanchard JJ. Anhedonia in schizophrenia: A review of assessment strategies. Schizophrenia Bulletin. 2006 Apr;32(2):259–273. PubMed PMID: WOS:000236106600015. - PMC - PubMed
    1. Axelrod BN, Goldman RS, Woodard JL, Alphs LD. Factor structure of the negative symptom assessment. Psychiatry Research. 1994 May;52(2):173–179. PubMed PMID: WOS:A1994NT91900007. - PubMed

Publication types